Inventor · disambiguated record
Donald L. Durden
Also filed as: DURDEN DONALD · DURDEN DONALD L
16 granted patents·9 pending applications·391 citations·filing 1998–2021
94Inventor score
Files withSEMAFORE PHARMACEUTICALS INC7SIGNALRX PHARMACEUTICALS INC7LOS ANGELES CHILDRENS HOSPITAL4UNIV INDIANA RES & TECH CORP3DURDEN DONALD L2
Top patents by PatentIndex Score
25 records- 0197US7745485B2Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathwaysUNIV INDIANA RES & TECH CORP·Filed 2008·Granted Jun 29, 2010·91 cites·6 claims
- 0295US7470721B2Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathwaysUNIV INDIANA RES & TECH CORP·Filed 2003·Granted Dec 30, 2008·81 cites·16 claims
- 0395US6777439B2Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathwaysUNIV INDIANA RES & TECH CORP·Filed 2001·Granted Aug 17, 2004·91 cites·3 claims
- 0493US9505780B2Thienopyranones as kinase and epigenetic inhibitorsSIGNALRX PHARMACEUTICALS INC·Filed 2015·Granted Nov 29, 2016·9 cites·2 claims
- 0591US10308662B2Thienopyranones as kinase and epigenetic inhibitorsSIGNALRX PHARMACEUTICALS INC·Filed 2017·Granted Jun 4, 2019·6 cites·11 claims
- 0691US6949537B2PI-3 kinase inhibitor prodrugsSEMAFORE PHARMACEUTICALS INC·Filed 2004·Granted Sep 27, 2005·63 cites·20 claims
- 0788US10174032B2Heterocyclic compound classes for signaling modulationSIGNALRX PHARMACEUTICALS INC·Filed 2015·Granted Jan 8, 2019·6 cites·2 claims
- 0884US7662977B2PI-3 kinase inhibitor prodrugsSEMAFORE PHARMACEUTICALS INC·Filed 2007·Granted Feb 16, 2010·8 cites·21 claims
- 0981US7396828B2PI-3 kinase inhibitor prodrugsSEMAFORE PHARMACEUTICALS INC·Filed 2005·Granted Jul 8, 2008·5 cites·2 claims
- 1079US11472814B2Thienopyranones and furanopyranones as checkpoint inhibitors and modulators of anti-tumor immunitySIGNALRX PHARMACEUTICALS INC·Filed 2018·Granted Oct 18, 2022·3 cites·18 claims
- 1179US9051561B2Asparaginase and treating diseases associated with asparagine dependenceLOS ANGELES CHILDRENS HOSPITAL·Filed 2012·Granted Jun 9, 2015·2 cites·36 claims
- 1279US8163691B2Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathwaysDURDEN DONALD L·Filed 2010·Granted Apr 24, 2012·5 cites·9 claims
- 1367US6991788B1Utilization of wolinella succinogenes asparaginase to treat diseases associated with asparagine dependenceLOS ANGELES CHILDRENS HOSPITAL·Filed 2003·Granted Jan 31, 2006·1 cites·10 claims
- 1467US2009011975A1Targeted bone marrow protection agentsSEMAFORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1561US6251388B1Utilization of Wolinella succinogenes asparaginase to treat diseases associated with asparagine dependenceLOS ANGELES CHILDRENS HOSPITAL·Filed 1998·Granted Jun 26, 2001·20 cites·17 claims
- 1659US2008292714A1Bone targeting of degradable drug filled nanoparticlesSEMAFORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1758US2017101418A1Thienopyranones as Kinase and Epigenetic InhibitorsSIGNALRX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1857US11760762B2Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitorsSIGNALRX PHARMACEUTICALS INC·Filed 2018·Granted Sep 19, 2023·0 cites·6 claims
- 1956US2004142395A1Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathwaysFiled 2004·Application pending·0 cites
- 2055US9353366B2Asparaginase and treating diseases associated with asparagine dependenceLOS ANGELES CHILDRENS HOSPITAL·Filed 2015·Granted May 31, 2016·0 cites·17 claims
- 2154US2012253020A1Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase PathwaysDURDEN DONALD L·Filed 2012·Application pending·0 cites
- 2254US2023165873A1Methods of Use for Single Molecule Compounds Providing Multi-Target Inhibition to Treat Covid 19SIGNALRX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2348US2002102251A1Utilization of Wolinella succinogenes asparaginase to treat diseases associated with asparagine dependenceFiled 2001·Application pending·0 cites
- 2448US2004198783A1Targeted bone marrow protection agentsSEMAFORE PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2545US2007203098A1Pten InhibitorsSEMAFORE PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Donald L. Durden files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →